TIPS Placement for Liver Cirrhosis

This trial aims to gather information on patients undergoing a procedure called TIPS, which helps manage portal hypertension (increased blood pressure in the liver). Researchers will track patients over five years to understand how this procedure affects their health and identify important clinical outcomes. Individuals scheduled for the TIPS procedure as part of their regular treatment are well-suited for this trial. As an unphased trial, it offers patients the opportunity to contribute to valuable research that could improve future treatment options.

A previous study showed that TIPS was successful in 96.6% of patients, indicating it can be a reliable procedure. However, some patients experienced major complications. Research has shown that older patients, particularly those aged 70 and above, had higher rates of hospital readmission, often due to hepatic encephalopathy, a brain condition related to liver disease.

Another study found that a small number of patients experienced bleeding from veins in the esophagus or stomach within 30 days after the procedure. Over time, the shunt used in the procedure tended to malfunction more frequently, with about 28.4% experiencing issues at 1 year and over 50% at 5 years.

Researchers are excited about TIPS (Transjugular Intrahepatic Portosystemic Shunt) placement for patients with portal hypertension because it offers a minimally invasive approach to reducing pressure in the portal vein, which is different from traditional surgical methods like portosystemic shunts. Unlike these surgical options, TIPS creates a pathway within the liver that can alleviate complications such as variceal bleeding and ascites. This technique not only potentially improves survival rates but also enhances the quality of life for patients by providing a quicker recovery time and reducing the need for repeated hospitalizations.

Research has shown that TIPS placement effectively manages liver cirrhosis complications, such as high blood pressure in the liver. One study found that a month after the procedure, 77.5% of patients improved. The procedure is technically successful, with some studies reporting a 100% success rate. Another study found that specific stents effectively manage severe symptoms, such as bleeding from swollen veins in the esophagus or stomach. Overall, TIPS has helped many patients with these challenging conditions.³⁶⁷⁸⁹